YSL
This article was originally published in The Rose Sheet
Executive Summary
Sales increase 6.7% to $138.4 mil. for fiscal first quarter (ended April 30), Gucci reports June 21. Yves Saint Laurent cosmetics sales increased 15.9% to $40 mil., while fragrance revenues were off 1% at $60.9 mil. Gucci purchased Sanofi's beauty business, which included YSL and couture, from Artemis, a holding company for Pinault-Printemps-Redoute, in November (1"The Rose Sheet" Nov. 22, 1999, p. 4). LVMH and PPR have engaged in talks to resolve disagreements surrounding PPR's alliance with Gucci. The two companies had been negotiating a sale of LVMH's 20 mil. Gucci shares for $100 per share, but the deal fell through
You may also be interested in...
Gucci Acquires $583.4 Mil. Sanofi Beauty Business From Artemis
Gucci is purchasing Sanofi Beaute from Artemis for $1 bil., giving the fashion house Yves Saint Laurent fragrances and cosmetics, Roger & Gallet, and fragrance licenses for Van Cleef & Arpels, Oscar de la Renta, Fendi and Krizia. Sanofi beauty sales total $583.4 mil.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.